The U.S. Food and Drug Administration has released a report stating that there are no significant industry-wide problems in the recovery of human tissues used for transplantation. The FDA's Human Tissue Task Force, an intra-agency group assembled in August to evaluate the effectiveness of FDA's tissue regulations, prepared the report. The task force recommended targeted inspections of U.S. companies that recover human tissues-including tendons, ligaments, bone and other musculoskeletal tissues-to look for more widespread problems. For more information, please visit http://www.fda.gov/bbs/topics/NEWS/2007/NEW01650.html.